Sciencast Management LP bought a new stake in HCA Healthcare Inc (NYSE:HCA) in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund bought 3,568 shares of the company’s stock, valued at approximately $331,000.
Other institutional investors also recently added to or reduced their stakes in the company. Parallel Advisors LLC grew its holdings in HCA Healthcare by 76.2% in the fourth quarter. Parallel Advisors LLC now owns 1,337 shares of the company’s stock valued at $117,000 after purchasing an additional 578 shares during the period. Bronfman E.L. Rothschild L.P. grew its holdings in HCA Healthcare by 108.0% in the fourth quarter. Bronfman E.L. Rothschild L.P. now owns 2,425 shares of the company’s stock valued at $213,000 after purchasing an additional 1,259 shares during the period. Kovack Advisors Inc. purchased a new stake in HCA Healthcare in the fourth quarter valued at approximately $234,000. Financial Counselors Inc. purchased a new stake in HCA Healthcare in the fourth quarter valued at approximately $243,000. Finally, Focused Wealth Management Inc purchased a new stake in HCA Healthcare in the fourth quarter valued at approximately $257,000. Hedge funds and other institutional investors own 73.48% of the company’s stock.
A number of equities research analysts recently issued reports on the stock. Cantor Fitzgerald restated a “buy” rating and issued a $115.00 target price on shares of HCA Healthcare in a report on Tuesday, January 30th. BMO Capital Markets boosted their target price on shares of HCA Healthcare from $96.00 to $115.00 and gave the company an “outperform” rating in a report on Thursday, February 1st. They noted that the move was a valuation call. Morgan Stanley boosted their target price on shares of HCA Healthcare from $84.00 to $91.00 and gave the company an “underweight” rating in a report on Thursday, February 1st. Sanford C. Bernstein restated a “market perform” rating and issued a $116.00 target price (up from $105.00) on shares of HCA Healthcare in a report on Thursday, February 1st. Finally, Leerink Swann boosted their price objective on shares of HCA Healthcare from $105.00 to $120.00 and gave the stock an “outperform” rating in a research note on Wednesday, January 31st. Three equities research analysts have rated the stock with a sell rating, six have issued a hold rating and eighteen have assigned a buy rating to the company. HCA Healthcare presently has a consensus rating of “Buy” and an average target price of $104.50.
HCA Healthcare Inc (NYSE HCA) opened at $102.77 on Friday. The firm has a market cap of $36,092.57, a price-to-earnings ratio of 17.30, a PEG ratio of 1.03 and a beta of 0.49. The company has a quick ratio of 1.36, a current ratio of 1.62 and a debt-to-equity ratio of -6.58. HCA Healthcare Inc has a 52 week low of $71.18 and a 52 week high of $106.84.
HCA Healthcare (NYSE:HCA) last announced its earnings results on Tuesday, January 30th. The company reported $2.12 earnings per share for the quarter, beating the consensus estimate of $1.87 by $0.25. The business had revenue of $11.56 billion during the quarter, compared to the consensus estimate of $11.19 billion. HCA Healthcare had a net margin of 4.89% and a negative return on equity of 49.49%. The business’s quarterly revenue was up 8.7% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.80 earnings per share. analysts anticipate that HCA Healthcare Inc will post 8.71 EPS for the current fiscal year.
The company also recently announced a quarterly dividend, which will be paid on Friday, March 30th. Stockholders of record on Thursday, March 1st will be paid a $0.35 dividend. The ex-dividend date of this dividend is Wednesday, February 28th. This represents a $1.40 annualized dividend and a dividend yield of 1.36%. HCA Healthcare’s dividend payout ratio (DPR) is presently 23.57%.
In other news, SVP Sandra L. Morgan sold 3,698 shares of the company’s stock in a transaction on Tuesday, February 6th. The shares were sold at an average price of $96.91, for a total value of $358,373.18. Following the completion of the transaction, the senior vice president now directly owns 5,410 shares in the company, valued at $524,283.10. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, SVP Joseph A. Sowell III sold 58,175 shares of the company’s stock in a transaction on Friday, January 26th. The shares were sold at an average price of $95.00, for a total transaction of $5,526,625.00. Following the completion of the transaction, the senior vice president now owns 40,536 shares of the company’s stock, valued at $3,850,920. The disclosure for this sale can be found here. Insiders sold 479,918 shares of company stock valued at $48,186,093 over the last 90 days. Insiders own 2.90% of the company’s stock.
COPYRIGHT VIOLATION NOTICE: “Sciencast Management LP Buys New Holdings in HCA Healthcare Inc (HCA)” was first published by The Ledger Gazette and is the property of of The Ledger Gazette. If you are accessing this story on another site, it was stolen and reposted in violation of US & international trademark and copyright law. The original version of this story can be read at https://ledgergazette.com/2018/03/17/sciencast-management-lp-buys-new-holdings-in-hca-healthcare-inc-hca.html.
HCA Healthcare Profile
HCA Healthcare, Inc, formerly HCA Holdings, Inc, is a holding company. The Company, through its subsidiaries, owns and operates hospitals and related healthcare entities. As of December 31, 2016, the Company operated in two geographically organized groups, including the National and American Groups. As of December 31, 2016, the National Group included 84 hospitals, which were located in Alaska, California, Florida, southern Georgia, Idaho, Indiana, northern Kentucky, Nevada, New Hampshire, South Carolina, Utah and Virginia.
Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare Inc (NYSE:HCA).
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.